MYH7 in cardiomyopathy and skeletal muscle myopathy

Mol Cell Biochem. 2024 Feb;479(2):393-417. doi: 10.1007/s11010-023-04735-x. Epub 2023 Apr 20.

Abstract

Myosin heavy chain gene 7 (MYH7), a sarcomeric gene encoding the myosin heavy chain (myosin-7), has attracted considerable interest as a result of its fundamental functions in cardiac and skeletal muscle contraction and numerous nucleotide variations of MYH7 are closely related to cardiomyopathy and skeletal muscle myopathy. These disorders display significantly inter- and intra-familial variability, sometimes developing complex phenotypes, including both cardiomyopathy and skeletal myopathy. Here, we review the current understanding on MYH7 with the aim to better clarify how mutations in MYH7 affect the structure and physiologic function of sarcomere, thus resulting in cardiomyopathy and skeletal muscle myopathy. Importantly, the latest advances on diagnosis, research models in vivo and in vitro and therapy for precise clinical application have made great progress and have epoch-making significance. All the great advance is discussed here.

Keywords: Cardiomyopathy; Genetic variant; Hypertrophic cardiomyopathy; MYH7; Myosin myopathy.

Publication types

  • Review

MeSH terms

  • Cardiac Myosins / genetics
  • Cardiomyopathies* / genetics
  • Heart
  • Humans
  • Muscle, Skeletal
  • Muscular Diseases* / genetics
  • Mutation
  • Myosin Heavy Chains / genetics
  • Phenotype

Substances

  • Myosin Heavy Chains
  • MYH7 protein, human
  • Cardiac Myosins